ShareValue scores for 688805.SHG: Valuation 31, Quality 55, Growth 58, Health 65.
688805.SHGSSE
Ningbo Jansen Superconducting Technologies Co., Ltd.
CN¥36.37
(-2.47%)
Updated
688805.SHGSSE
Ningbo Jansen Superconducting Technologies Co., Ltd.
Updated
Pulse
Pulse
Fundamental Rating
Value Trap Risk
If P/E met sector median
Rating
Trap Risk
P/E to median
vs Shanghai-listed Healthcare stocks
Company Details
Ningbo Jansen Superconducting Technologies Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of core components for medical magnetic resonance imaging (MRI) equipment in China and internationally. The company offers superconducting magnets, permanent magnets, and gradient coils. It also provides routine services for superconducting magnets, including replenishing liquid helium, excitation, shimming, and field reduction; specialized services for superconducting magnets, such as refrigeration system maintenance and relocation; permanent magnet field homogenization services; magnet transportation services, including land, sea, and air transport; and other customized services related to magnets. In addition, the company engages in trading and investing activities. Ningbo Jansen Superconducting Technologies Co., Ltd. was incorporated in 2013 and is headquartered in Cixi, China.
Score Analysis
AI Investment Thesis
Ningbo Jansen Superconducting Technologies Co., Ltd. looks overvalued versus Shanghai-listed Healthcare stocks, with P/B of 4.96 higher than 80% of peers and EV/EBITDA of 44.2 higher than 73%.
Quality is the standout: a 14.94% net margin and 8.69% ROE contrast with loss-making global sector averages, though Q3 weighted ROE slipped 0.68 points year-on-year.
The 29 October 2026 third-quarter report showed revenue up 42.19% and net profit up 96.22% year-on-year, confirming accelerating superconducting magnet demand.